NL-OMON20157招募中不适用
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer. An IKZ-based phase II feasibility study.
dr K. Bosscha, surgeondr J.F.M. Pruijt, oncologistdrs A.E. Dassen, resident in training for surgery0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Ib-IVa histological proven resectable gastric adenocarcinoma, including gastro-oesophageal junction/cardia carcinoma;
- •2. Siewert 2 and 3;
排除标准
- •1. Inoperable patients;
- •2. Previous or other current malignancies, with the exception of adequately treated in situ carcinoma of the cervix uteri or non-melanoma skin cancer;
研究者
相似试验
已完成
2 期
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer An IKZ-based phase II feasibility studygastric carcinoma100179901001799110017998gastric cancerNL-OMON31603Jeroen Bosch Ziekenhuis50
进行中（未招募）
不适用
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine combined with Protocolized Surgery in Resectable Gastric Cancer - DoCCSEUCTR2007-007273-23-NLJeroen Bosch Hospital
已完成
2 期
Phase II study of neoadjuvant and adjuvant docetaxel/cisplatin/5-fluorouracil in resectable esophagus canceresophagus cancerJPRN-UMIN000005588Jikei university of medicine department of surgery, department of oncology and hematology12
招募中
2 期
eoadjuvant DOS treatment for advanced esophageal cancerEsophageal cancerJPRN-jRCTs041210023Kodera Yasuhiro45
尚未招募
2 期
Multicenter phase II study of neoadjuvant chemotherapy of gemcitabine+nab-paclitaxel therapy for patients with resectable pancreatic cancer.Invasive ductal adenocarcinomaJPRN-UMIN000028101Division of Hepato-biliary-pancreatic Surgery Department of Surgery, Kobe University Graduate School of Medicine45